Overview

• Akihito was hospitalized on July 14 at the University of Tokyo Hospital to begin careful titration of a newly prescribed oral cardiac medication for asymptomatic myocardial ischemia and right heart failure.
• Continuous ECG monitoring was employed to track potential side effects, including bradycardia and arrhythmias, during dosage adjustments.
• Premedication tests during the stay revealed a supraventricular arrhythmia, leading physicians to adapt his activity guidelines accordingly.
• The Imperial Household Agency, led by Director Yasuhiko Nishimura, managed the treatment protocols and provided regular updates on the former emperor’s progress.
• Empress Emerita Michiko accompanied him at discharge on July 18, and he will continue outpatient observation under strict Imperial health protocols.